Heat shock protein-based vaccines and immunotherapies
US7420037B2 · kind B2 · utility
4Cited by
17References
45Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 12, 2004 |
| Grant date | Sep 2, 2008 |
| Priority date | — |
| Expiry date | Feb 12, 2024 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Hybrid antigens comprising an antigenic domain and improved heat shock protein binding domains are described which are useful for the induction of an immune response to the antigenic domain and thus can be used to treat infectious diseases and cancers that express an antigen of the antigenic domain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.